310 related articles for article (PubMed ID: 17545193)
1. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
[TBL] [Abstract][Full Text] [Related]
2. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
[TBL] [Abstract][Full Text] [Related]
3. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Hamburger J; Richards A; Rauz S; Emery P
Ann Rheum Dis; 2008 Nov; 67(11):1541-4. PubMed ID: 18276741
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome.
Virkki LM; Porola P; Forsblad-d'Elia H; Valtysdottir S; Solovieva SA; Konttinen YT
Arthritis Care Res (Hoboken); 2010 Jan; 62(1):118-24. PubMed ID: 20191499
[TBL] [Abstract][Full Text] [Related]
5. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
Finckh A; Berner IC; Aubry-Rozier B; So AK
J Rheumatol; 2005 Jul; 32(7):1336-40. PubMed ID: 15996074
[TBL] [Abstract][Full Text] [Related]
7. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
8. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Puéchal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J
Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
[TBL] [Abstract][Full Text] [Related]
10. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
[TBL] [Abstract][Full Text] [Related]
11. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
Valtysdóttir ST; Wide L; Hällgren R
J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
[TBL] [Abstract][Full Text] [Related]
12. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
Chang DM; Lan JL; Lin HY; Luo SF
Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
[TBL] [Abstract][Full Text] [Related]
15. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
16. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome.
Porola P; Straub RH; Virkki LM; Konttinen YT; Nordström DC
Scand J Rheumatol; 2011; 40(5):387-90. PubMed ID: 21877998
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormones in primary Sjögren's syndrome.
Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR
J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
[TBL] [Abstract][Full Text] [Related]
18. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
Vriezekolk JE; Geenen R; Hartkamp A; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
J Rheumatol; 2005 Dec; 32(12):2351-5. PubMed ID: 16331762
[TBL] [Abstract][Full Text] [Related]
19. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
[TBL] [Abstract][Full Text] [Related]
20. Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate.
Valtysdottir ST; Wide L; Hallgren R
Ann Rheum Dis; 2003 Sep; 62(9):875-9. PubMed ID: 12922962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]